文献速递MDS 与骨髓增殖性肿瘤造血干细胞移植与细胞治疗

抑制MDS祖细胞中的LSD1可恢复CD141Hi常规树突状细胞的分化

Inhibition of LSD1 in MDS progenitors restores differentiation of CD141Hi conventional dendritic cells.
PubMed 文献 · Leukemia · 2020-02-25

该研究探讨骨髓增生异常综合征(MDS)中CD141Hi常规树突状细胞(cDCs)减少的机制。研究发现MDS骨髓中CD141Hi cDCs减少且与总生存期缩短相关,其祖细胞IRF8表达降低;药物抑制LSD1可促进MDS祖细胞向CD141Hi cDC分化,提示表观遗传干预可能辅助免疫治疗。

要点

  • MDS骨髓中CD141Hi cDCs减少,且与总生存期缩短相关。
  • MDS骨髓中定向DC分化的祖细胞减少且IRF8表达降低。
  • 药物抑制LSD1可促进MDS祖细胞向CD141Hi cDC分化。

核心结论

  • MDS骨髓中CD141Hi cDCs减少且与总生存期缩短相关,抑制LSD1可恢复其分化。

研究设计与样本

  • 基于MDS骨髓样本的实验研究,比较CD141Hi cDCs数量与总生存期,并检测DC祖细胞IRF8表达及LSD1抑制后的分化。

主要发现

  • MDS患者骨髓中CD141Hi cDCs数量减少,而其他DC群体未见类似减少。
  • CD141Hi cDCs减少的MDS患者总生存期缩短。
  • MDS骨髓中定向DC分化的祖细胞数量减少且IRF8表达水平降低。
  • 药物抑制LSD1可促进MDS祖细胞向CD141Hi cDC分化。

临床怎么用

  • LSD1抑制可能作为恢复MDS中CD141Hi cDC分化的表观遗传干预策略。
  • 该策略或可作为MDS免疫治疗的潜在辅助手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The use of immunotherapy to treat patients with myelodysplastic syndromes (MDS) shows promise but is limited by our incomplete understanding of the immunologic milieu. In solid tumors, CD141Hi conventional dendritic cells (CD141Hi cDCs) are necessary for antitumor immunosurveillance and the response to immunotherapy. Here, we found that CD141Hi cDCs are reduced in MDS bone marrow and based on the premise established in solid tumors, we hypothesized that reduced numbers of CD141Hi cDCs are associated with inferior overall survival in MDS patients. We found that MDS patients with reduced numbers of CD141Hi cDCs, but not other DC populations, showed reduced overall survival. To examine the basis for reduction in CD141Hi cDCs, we found fewer numbers of progenitors committed to DC differentiation in the MDS bone marrow and these progenitors expressed lower levels of interferon regulatory factor-8 (IRF8), a master regulator of CD141Hi cDC differentiation. To rescue impaired CD141Hi cDC differentiation, we used pharmacologic inhibition of lysine-specific demethylase 1A (LSD1) to promote CD141Hi cDC differentiation by MDS progenitors. These data reveal a previously unrecognized element of the MDS immunologic milieu. Epigenetic regulation of CD141Hi cDC differentiation offers an intriguing opportunity for intervention and a potential adjunct to immunotherapy for patients with MDS.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Srivastava P, Tzetzo SL, Gomez EC, et al. Inhibition of LSD1 in MDS progenitors restores differentiation of CD141Hi conventional dendritic cells. Leukemia. 2020. PMID: 32099035. doi:10.1038/s41375-020-0765-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。